Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 1094 results for "us fda"

FDA sets minimum sales age of 18 for e-cigarettes, cigars
Business Insider

U.S. FDA sets minimum sales age of 18 for e-cigarettes, cigars

NEW YORK May 5 (Reuters) - The U.S. Food and Drug Administration on Thursday issued highly anticipated regulations for all cigars, e-cigarettes, pipe tobacco and other products that set a minimum age of 18 for sale across all areas. The ... Reuters Africa, 51 minutes ago
Medical News Today

US FDA approves Acadia Pharma's Nuplazid to treat hallucinations, delusions associated with Parkinson's disease

The US Food and Drug Administration approved Acadia Pharmaceuticals Inc's Nuplazid (pimavanserin) tablets, the first drug approved to treat hallucinations and delusions associated with psychosis experienced by some people with Parkinson's disease. ...
 PharmaBiz2 days ago FDA approves first Parkinson's psychosis drug  Pharma Business International1 day ago FDA approves first drug for hallucinations and delusions associated with PD  American Nurse Today3 minutes ago FDA approves Acadia's Nuplazid to treat Parkinson's disease psychosis  Pharmaceutical Business Review3 days ago
ABC News

FDA Takes Aim at LGBT Tobacco Use in New CampaignMay 2, 2016, 6:27 PM

The U.S. Food and Drug Administration launched a $35.7 million anti-tobacco campaign today focused on lesbian, gay, bisexual and transgender (LGBT) young adults. The new campaign, , includes four videos that aim to prevent and reduce smoking among ...
 ABC News2 days ago FDA Launches Campaign To Curb Tobacco Use Among LGBT Youth  RTTNews.com2 days ago FDA's new education campaign for LGBT young adults aims to prevent, reduce tobacco use  News-Medical.Net2 days ago FDA launches public education campaign to prevent and reduce tobacco use among LGBT young adults  Drugs.com2 days ago

PharmaCyte Biotech, Inc. (PMCB: OTCQB) | PharmaCyte Biotech Clears Major Milestone on Path to FDA Clinical Trial

) - PharmaCyte Biotech (OTCQB: PMCB) has now reached a point in its life cycle where it is ready to start working with the U.S. FDA to get the company's Phase 2b clinical trial in advanced pancreatic cancer underway. Let that sink in for a moment.
 OTC Markets31 minutes ago PHARMACYTE BIOTECH : Clears Major Milestone on Path to FDA Clinical Trial  4 Traders58 minutes ago PharmaCyte Biotech Clears Major Milestone on Path to FDA Clinical Trial  Yahoo! Finance UK and Ireland23 minutes ago

FDA to Regulate E-Cigarettes, Ban Sales to Minors

By Tripp Mickle The U.S. government on Thursday said it was assuming regulatory authority over e-cigarettes and all other tobacco products with rules that will prohibit sales to anyone under 18 and require manufacturers to submit products for ...
 4 Traders29 minutes ago

FDA Grants Orphan Drug Designation to Allena's Investigational Therapy for the Treatment of Pediatric Hyperoxaluria

Allena Pharmaceuticals, Inc., a specialty biopharmaceutical company focused on developing and commercializing innovative, non-systemic, oral protein therapeutics to treat metabolic and orphan diseases, today announced that the U.S. Food and Drug ...
 4 Traders45 minutes ago

FDA takes significant steps to protect Americans from dangers of tobacco through new regulation

/PRNewswire-USNewswire/ -- Today, the U.S. Food and Drug Administration finalized a rule extending its authority to all tobacco products, including e-cigarettes, cigars, hookah tobacco and pipe tobacco, among others. This historic rule helps ...
 BioSpace38 minutes ago

This Week In Pharma: Is Anavex's Hype Based On Data Or Anecdotes? Does Acadia's NUPLAZID Have Potential As The First FDA Approved Drug In Parkinson's Psychosis Space?

By Slingshot Contributor Phil Loria This week I am covering two micro-cap companies who are at different stages of development with their lead product candidates. Anavex ( AVXL ) was up 23% premarket on April 25th after news broke that ...
 Seeking Alpha48 minutes ago

FDA Advisory Committees To Review KemPharm's Abuse-Deterrent Drug Candidate Apadaz

KemPharm, Inc. (NASDAQ:KMPH), a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, today announced that NASDAQ halted trading of KemPharm's common stock this morning. The Anesthetic and ...
 Minyanville2 hours ago

US FDA approves Boston Scientific's IntellaNav XP and IntellaNav MiFi XP navigation-enabled ablation catheters

Boston Scientific has received US Food and Drug Administration (FDA) approval for two catheters that can be used with the Rhythmia Mapping System. The IntellaNav XP and the IntellaNav MiFi XP navigation-enabled ablation catheters designed to map ...
 PharmaBiz2 hours ago Boston Scientific wins FDA nod for Rhythmia cardiac mapping and ablation catheters  MassDevice1 day ago FDA Clears Boston Scientific's Navigation-Enabled Ablation Catheters  BioSpace1 day ago Boston Scientific gets FDA approval for two navigation-enabled ablation catheters  Medical Devices Business Review1 day ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less